|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/43 | (2006.01) |
| A61P 3/06 | (2006.01) |
| (11) | Number of the document | 3482767 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18199358.5 |
| Date of filing the European patent application | 2010-08-28 | |
| (97) | Date of publication of the European application | 2019-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation | 2022-01-10 |
| (30) | Number | Date | Country code |
| 238113 P | 2009-08-28 | US |
| (72) |
SCHUCHMAN, Edward H. , US
DESNICK, Robert J. , US
COX, Gerald F. , US
ANDREWS, Laura P. , US
MURRAY, James M. , US
|
| (73) |
Icahn School of Medicine at Mount Sinai ,
One Gustave L. Levy Place, New York, NY 10029,
US
Genzyme Corporation , 450 Water Street, Cambridge, MA 02141, US |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Didinamos dozės fermentų pakaitinė terapija, skirta rūgštinės sfingomielinazės nepakankamumui gydyti |
| DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY |
| Payment date | Validity (years) | Amount | |
| 2025-07-31 | 16 | 347.00 EUR |
| 2026-08-28 |